By using patient derived GSCs we demonstrate that MT1-MMP mediates GBM invasion both in vitro and in vivo, via its effector protease MMP2; whereas the radiation response is a function of MT1-MMPs ability to control replication fork stability. The gene discussed is MMP14; the disease is glioblastoma.